PRESS RELEASE published on 06/23/2025 at 10:02, 1 year ago Viromed Medical AG: Cold plasma technology shows potential to significantly reduce deaths in ventilated patients Viromed Medical AG's cold plasma technology shows potential to significantly reduce deaths in ventilated patients according to preclinical study, addressing a critical issue in intensive care medicine Preclinical Study Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Technology Intensive Care Medicine
BRIEF published on 06/06/2025 at 16:50, 1 year 1 month ago Viromed Medical AG Announces Leadership Changes Supervisory Board Leadership Change Viromed Medical AG Cold Plasma Technology Thomas Gutschlag
BRIEF published on 06/06/2025 at 16:50, 1 year 1 month ago Viromed Medical AG annonce des changements au sein de sa direction Changement De Direction Conseil De Surveillance Viromed Medical AG Technologie Du Plasma Froid Thomas Gutschlag
PRESS RELEASE published on 06/06/2025 at 16:45, 1 year 1 month ago Viromed Medical AG plans change in the Supervisory Board and Chairman of the Supervisory Board Viromed Medical AG plans change in the Supervisory Board and Chairman as Dr. Thomas Gutschlag to take over. Founder Dr. Jan Delphendahl resigns. Focus on cold plasma technology Supervisory Board Corporate News Viromed Medical AG Cold Plasma Technology Dr. Thomas Gutschlag
BRIEF published on 05/15/2025 at 18:15, 1 year 1 month ago Viromed Medical AG's Cold Plasma Therapy Shows 100% Efficacy Against VAP Viromed Medical AG Cold Plasma Therapy Ventilator-associated Pneumonia In Vitro Study MRSA Bacteria
BRIEF published on 05/15/2025 at 18:15, 1 year 1 month ago La thérapie au plasma froid de Viromed Medical AG montre une efficacité de 100 % contre la PAVM Viromed Medical AG Thérapie Par Plasma Froid Pneumonie Associée À La Ventilation Mécanique Bactéries SARM Étude In Vitro
PRESS RELEASE published on 05/15/2025 at 18:10, 1 year 1 month ago Viromed Medical AG: Revolutionary cold plasma therapy for the treatment of ventilator-associated pneumonia (VAP) shows 100% efficacy in an in vitro study with MRSA and human lung cells (alveoli) Viromed Medical AG announces groundbreaking results with cold plasma therapy for ventilator-associated pneumonia (VAP) in an in vitro study. Findings show 100% efficacy against MRSA bacteria without lung cell damage Viromed Medical AG Cold Plasma Therapy Ventilator-associated Pneumonia In Vitro Study VAP
BRIEF published on 04/25/2025 at 12:29, 1 year 2 months ago Viromed Enters European Cosmetics Market with Exclusive ViroCAP® Deal Viromed Medical AG Cold Plasma Technology ViroCAP® My Plasma European Cosmetics Market Landsberg First Class Aesthetic
BRIEF published on 04/25/2025 at 12:29, 1 year 2 months ago Viromed entre sur le marché européen des cosmétiques avec un accord exclusif ViroCAP® Viromed Medical AG Technologie Du Plasma Froid ViroCAP® Mon Plasma Marché Européen Des Cosmétiques Esthétique De Première Classe Landsberg
PRESS RELEASE published on 04/25/2025 at 12:24, 1 year 2 months ago Exclusive contract for ViroCAP® My Plasma with Landsberg First Class Aesthetic opens up Viromed's entry into the European cosmetics market Viromed Medical AG partners with Landsberg First Class Aesthetic to introduce ViroCAP® My Plasma into the European cosmetics market, enhancing aesthetic treatments with cold plasma technology Viromed Medical AG Cold Plasma Technology ViroCAP® My Plasma European Cosmetics Market Landsberg First Class Aesthetic
Published on 07/06/2026 at 19:25, 37 minutes ago Critical Elements Provides an Update on Its 10,000-Meter Summer Drill Program at Rose West
Published on 07/06/2026 at 19:25, 37 minutes ago Critical Elements Fait Le Point Sur Programme De Forage Estival De 10 000 Mètres À Rose Ouest
Published on 07/06/2026 at 17:00, 3 hours 2 minutes ago PPX Mining Reports Second Consecutive Monthly Historical Record of Net Profit Interest Earned at Callanquitas Mine
Published on 07/06/2026 at 14:30, 5 hours 32 minutes ago As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo
Published on 07/06/2026 at 14:15, 5 hours 47 minutes ago Gold Terra Announces C$9.7 Million Life Offering, Including Participation From Strategic Shareholder David Harquail
Published on 07/06/2026 at 19:41, 20 minutes ago AVANTAGE : Founding shareholders of Voyageurs du Monde announce shareholding reorganisation and proposed Public Tender Offer
Published on 07/06/2026 at 19:41, 20 minutes ago AVANTAGE : Les Fondateurs de Voyageurs du Monde annoncent une réorganisation actionnariale et le lancement d'un projet d'offre publique
Published on 07/06/2026 at 19:00, 1 hour 2 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 29 JUIN 2026 au 03 JUILLET 2026
Published on 07/06/2026 at 18:00, 2 hours 2 minutes ago BOA Concept Group accélère ses partenariats internationaux grâce à sa filiale canadienne
Published on 07/06/2026 at 18:00, 2 hours 2 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 26 juin 2026
Published on 07/06/2026 at 18:00, 2 hours 2 minutes ago Information concerning the total number of voting rights and shares in the share capital as of June 26, 2026
Published on 07/06/2026 at 18:00, 2 hours 2 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 juin 2026
Published on 07/06/2026 at 17:59, 2 hours 3 minutes ago Acquisition of Xypex in construction chemicals, a leader in high value-added waterproofing solutions